ACR COVID-19 Vaccine Guidance Recommends Vaccination, Addresses Immunosuppressant Drugs & Patient Concerns

The American College of Rheumatology (ACR) has released its COVID-19 Vaccine Clinical Guidance Summary that provides an official recommendation to vaccinate rheumatology patients with musculoskeletal, inflammatory and autoimmune diseases. Important considerations and caveats on how to approach vaccination are included for patients with high disease activity and/or those taking immunosuppressant treatments.

Read more

COVID-19 Infection Rates Low in People with Rheumatic Diseases, Most Report Mild Illness

A new study shows that the COVID-19 infection incidence has been low in people with rheumatic diseases, and most of those infected experience a mild course of illness. Additionally, fatalities have been low among rheumatic disease patients infected with COVID-19. Details of this research was presented at ACR Convergence, the American College of Rheumatology’s annual meeting.

Read more

Minority Patients with Rheumatic Diseases Have Worse COVID-19 Outcomes, More Likely to Be Hospitalized

New research at ACR Convergence, the American College of Rheumatology’s annual meeting, reveals that people of color with rheumatic disease have worse health outcomes from COVID-19 infection, are more likely to be hospitalized to treat their coronavirus infection, and are more likely to require invasive ventilator treatment.

Read more

American College of Rheumatology Secures $7M Grant to Address Gaps in Lupus Care and Treatment

The American College of Rheumatology (ACR) was recently awarded a $7M grant to reduce inequities in symptom recognition, care and disease management of systemic lupus erythematosus (lupus). The grant, which will be led by the ACR’s Collaborative Initiatives (COIN) department, begins on Sept. 30.

Read more

Rheumatology Leaders and Patient Advocates Urge Congress to Address Care Challenges Exacerbated by COVID-19 During Advocates for Arthritis

The American College of Rheumatology (ACR) will hold its first virtual Advocates for Arthritis event on Tuesday, Sept. 15, where more than 120 rheumatologists, rheumatology health professionals, and patient advocates will meet with lawmakers via video to discuss the healthcare challenges they are facing in the midst of COVID-19.

Read more

“My Disease May Be Invisible, But I’m Not”: Patients Tell Their Stories During Rheumatic Disease Awareness Month

The American College of Rheumatology (ACR) and Simple Tasks™ will recognize the fifth annual Rheumatic Disease Awareness Month (RDAM) this September with an awareness campaign that focuses on amplifying patient voices and experiences.

Read more

During Virtual Hill Visits, Rheumatology Leaders Urge Lawmakers to Provide Targeted COVID-19 Relief for Healthcare Practices

In virtual meetings with lawmakers and on Twitter tomorrow, physician and health professional leaders from the American College of Rheumatology are sounding the alarm about the economic impact of COVID-19 on rheumatology practices and the urgent need for targeted relief to help specialty practices remain solvent and continue to serve patients.

Read more

ACR Releases First Guideline to Address Reproductive Health for Patients with Rheumatic Diseases

This is the first, evidence-based guideline related to the management of reproductive health issues for all patients with rheumatic diseases. With 131 recommendations, the guideline offers general precepts that provide a foundation for its recommendations and good practice statements.

Read more

HSS Experts Share Best Practices for Developing and Implementing Effective Educational Programs for Diverse Patients with Rheumatic Conditions

At the 2019 American College of Rheumatology/Association of Rheumatology Professionals annual meeting in Atlanta, experts from the HSS Education Institute at Hospital for Special Surgery (HSS) presented their method for developing and implementing effective educational programs for diverse patients with rheumatic conditions.

Read more